Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokineticsSBS-147 is a novel and potent oral ...
Clinical Trials Arena on MSN
Sparian commences phase I trial of SBS-147 for pain treatment
The therapy’s development from Phase I to Phase II is funded by a $15m NIH/NIDA HEAL grant.
- Data to be presented from Phase II study of two patients with short bowel syndrome in an ongoing study of apraglutide BASEL, Switzerland, May 17, 2019 /PRNewswire/ -- Therachon AG ("Therachon"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results